Monday June 26th 2017

‘People’ Archives

VIDEO: Being treated for MS led to a marriage proposal for couple

VIDEO: Being treated for MS led to a marriage proposal for couple

Last month, Rusty Parsons walked into the Mellen Center at the Cleveland Clinic, the same place he has sat through numerous doctors appointments in his battle with multiple sclerosis, and faced his biggest challenge. Sitting in a chair across the room was the love of his [Read More]

Forced to seek MS treatment in U.S

Forced to seek MS treatment in U.S

We just had the most amazing and successful fundraiser at the Fogolar Furlan for my husband, Barry Ashby. He suffers with multiple sclerosis (MS), has narrowed neck veins and goes to California on March 22 for the “Liberation Therapy” (CCSVI), unfortunately, not [Read More]

Fundraiser set to help MS sufferer

Fundraiser set to help MS sufferer

A group of young people have teamed up with local businesses to help a Riverview woman suffering from multiple sclerosis make the trip to the United States for a life-altering medical procedure. The group has launched the “Save-a-mom” fundraising campaign to [Read More]

 Page 1 of 21  1  2  3  4  5 » ...  Last » 

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]